Due to the higher abundance of Aη peptides in the brain than the well-established Aβ peptides (18) and their potential involvement in impairing long-term potentiation (LTP) (20), it is intriguing to speculate that this non-canonical APP processing pathway may be implicated in Alzheimer’s disease. The gene discussed is APP; the disease is early-onset autosomal dominant Alzheimer disease.